company background image
POLYMED logo

Poly Medicure NSEI:POLYMED Rapport sur les actions

Dernier prix

₹2.61k

Capitalisation boursière

₹263.8b

7D

-3.8%

1Y

71.7%

Mise à jour

19 Nov, 2024

Données

Finances de l'entreprise +

Poly Medicure Limited

NSEI:POLYMED Rapport sur les actions

Capitalisation boursière : ₹263.8b

POLYMED Aperçu des actions

Poly Medicure Limited fabrique et vend des dispositifs médicaux en Inde et au niveau international. Plus de détails

POLYMED analyse fondamentale
Score flocon de neige
Évaluation0/6
Croissance future4/6
Performances passées4/6
Santé financière6/6
Dividendes0/6

Poly Medicure Limited Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Poly Medicure
Historique des cours de bourse
Prix actuel de l'action₹2,607.70
Plus haut sur 52 semaines₹3,357.80
Plus bas sur 52 semaines₹1,361.00
Bêta0.34
1Variation sur 1 mois6.33%
Variation sur 3 mois19.45%
Variation sur 1 an71.67%
3Variation sur 3 ans173.47%
Variation sur 5 ans1,160.37%
Évolution depuis l'introduction en bourse7,162.52%

Nouvelles et mises à jour récentes

Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Nov 02
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Recent updates

Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Nov 02
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00

Sep 14
Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00

After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar

Sep 06
After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar

Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet

Aug 14
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138

Jul 27
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138

Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Jul 11
Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Rendement pour les actionnaires

POLYMEDIN Medical EquipmentIN Marché
7D-3.8%-3.7%-1.8%
1Y71.7%65.7%27.2%

Rendement vs Industrie: POLYMED a dépassé le secteur Indian Medical Equipment qui a rapporté 65.7 % au cours de l'année écoulée.

Rendement vs marché: POLYMED a dépassé le marché Indian qui a rapporté 27.2 % au cours de l'année écoulée.

Volatilité des prix

Is POLYMED's price volatile compared to industry and market?
POLYMED volatility
POLYMED Average Weekly Movement6.3%
Medical Equipment Industry Average Movement6.7%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Cours de l'action stable: POLYMED n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de POLYMED ( 6% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
19956,300Himanshu Baidwww.polymedicure.com

Poly Medicure Limited fabrique et vend des dispositifs médicaux en Inde et à l'étranger. Elle propose des dispositifs de perfusion, tels que des canules intraveineuses, des cathéters de ligne médiane, des canules artérielles, des robinets d'arrêt à trois voies, des sets de perfusion intraveineuse, des collecteurs, des sets de perfusion à ailettes de sécurité, des sets d'extension de type T, des stylos/mandrins avec luer locks, des pointes d'accès aux flacons, des sets d'administration de fluides à volume mesuré, des lignes d'extension, des cathéters veineux centraux, des manomètres CVP, des connecteurs sans aiguille, des seringues préremplies, des accès vasculaires et des sets d'administration de sang. La société fournit également des sondes nasogastriques et des sondes d'alimentation pour nourrissons, des sondes d'alimentation gastro-duodénales et des cathéters ombilicaux ; des poches de collecte d'urine, des sondes à ballonnet de Foley, des kits d'irrigation, des sondes de drainage urinaire et des poches de collecte d'urine avec des compteurs de volume mesuré ; et des tubes endotrachéaux et de trachéotomie, des extracteurs de mucus, des circuits de ventilateur, des circuits de bain, des supports de cathéter, des aiguilles spinales, des filtres HME et des voies respiratoires à masque laryngé.

Poly Medicure Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Poly Medicure se comparent-ils à sa capitalisation boursière ?
POLYMED statistiques fondamentales
Capitalisation boursière₹263.78b
Bénéfices(TTM)₹2.95b
Recettes(TTM)₹15.22b

89.5x

Ratio P/E

17.3x

Ratio P/S

Le site POLYMED est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
POLYMED compte de résultat (TTM)
Recettes₹15.22b
Coût des recettes₹5.14b
Marge brute₹10.08b
Autres dépenses₹7.13b
Les revenus₹2.95b

Derniers bénéfices déclarés

Sep 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)29.10
Marge brute66.23%
Marge bénéficiaire nette19.37%
Ratio dettes/capitaux propres6.1%

Quelles ont été les performances à long terme de POLYMED?

Voir les performances historiques et les comparaisons

Dividendes

0.1%

Rendement actuel des dividendes

11%

Ratio de distribution